Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

リスクのある胎児.

T Chard

    Lancet (London, England)
    |October 12, 1974
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Mid-trimester levels of placental protein 5 are not predictive of preterm labour.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018
    Same author

    Serum placental-type alkaline-phosphatase levels in patients with epithelial ovarian-carcinoma.

    International journal of oncology·2011
    Same author

    Release of oxytocin by the human fœtus during labour abstract.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Illustrations pertaining to the medical life of Doctor John Cochran.

    Bulletin of the history of medicine·2010
    Same author

    Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1.

    The Journal of endocrinology·2004
    Same author

    Does the fetus lose weight in utero following fetal death: a study in preterm infants.

    BJOG : an international journal of obstetrics and gynaecology·2002
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る